Trial intelligence / Profile preview

Randomized trial of TOF ratio at least 0.9 versus clinical assessment before extubation

PACTR201501001021110Completed

Sponsor
Aga Khan University
Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of cisatracurium (2 arms), sponsored by Aga Khan University. Primary endpoint: Incidence of critical respiratory events in PACU. Started Apr 2014; status: completed.

02

Drugs

cisatracurium

Beyond the preview

Go deeper on PACTR201501001021110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201501001021110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call